Atlas Trials

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension

Clinical trial NCT04474899 · UNKNOWN

Trial details

NCT number
NCT04474899
Sponsor
Royal Perth Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
ObesityHypertension
Start date
2015-06-24
Primary completion
2024-02-24
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.